CTCBIO Inc. (KOSDAQ:060590)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,700.00
+350.00 (5.51%)
At close: Aug 13, 2025, 3:30 PM KST

CTCBIO Revenue

CTCBIO had revenue of 34.10B KRW in the quarter ending March 31, 2025, with 2.72% growth. This brings the company's revenue in the last twelve months to 145.31B, up 6.98% year-over-year. In the year 2024, CTCBIO had annual revenue of 144.41B with 4.74% growth.

Revenue (ttm)
145.31B
Revenue Growth
+6.98%
P/S Ratio
1.10
Revenue / Employee
593.11M
Employees
245
Market Cap
160.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024144.41B6.53B4.74%
Dec 31, 2023137.88B-27.33B-16.54%
Dec 31, 2022165.21B24.89B17.74%
Dec 31, 2021140.32B10.29B7.91%
Dec 31, 2020130.03B-6.09B-4.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.59T
SK hynix 77.21T
LG Energy Solution 25.76T
Samsung Biologics 4,898.69B
Hyundai Motor Company 178.98T
Hanwha Aerospace 15.28T
Doosan Enerbility 15.88T
KB Financial Group 15.69T
Revenue Rankings